Cleared Traditional

K212167 - R350 guidewire, Spectre guidewire, Raider guidewire, Bandit guidewire, Warrior guidewire (FDA 510(k) Clearance)

Feb 2022
Decision
212d
Days
Class 2
Risk

K212167 is an FDA 510(k) clearance for the R350 guidewire, Spectre guidewire, Raider guidewire, Bandit guidewire, Warrior guidewire. This device is classified as a Wire, Guide, Catheter (Class II - Special Controls, product code DQX).

Submitted by Vascular Solutions, LLC (Minneapolis, US). The FDA issued a Cleared decision on February 9, 2022, 212 days after receiving the submission on July 12, 2021.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1330.

Submission Details

510(k) Number K212167 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 12, 2021
Decision Date February 09, 2022
Days to Decision 212 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DQX - Wire, Guide, Catheter
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1330

Similar Devices - DQX Wire, Guide, Catheter

All 27
FMD Peripheral Guide Wire F-14 Flex 6
K260544 · FMD Co., Ltd. · Mar 2026
Enroute 0.014'' Transcarotid Guidewire
K253746 · Lake Region Medical · Mar 2026
EmeryGlide™ (EG18008901)
K253262 · Nano4imaging GmbH · Mar 2026
Splashwire Hydrophilic Guide Wire (MSWSTD35150J3)
K253847 · Merit Medical Ireland, Ltd. · Jan 2026
InQwire Super Stiff Guide Wire (IQSS32180J3)
K251385 · Merit Medical Ireland, Ltd. · Jan 2026
Solo Pace Fusion System (SOLOFUSE1)
K252674 · Solo Pace, Inc. · Jan 2026